Patient 1 is a 70-year-old woman that presented with a biopsy-proven lesion of Bowen's disease [squamous cell carcinoma (SCC) in situ] on the left arm. She was 17 years status post-renal transplantation for which she was taking imuran and prednisone. She recently had a lentigo maligna excised from her cheek. Physical examination revealed a 3 cm ϫ 3 cm mildly hyperkeratotic pink/red plaque on the left dorsal arm. Multiple fine black hairs were noted on her arm, including those within the lesion.
Therapeutic Challenge
We sought a method to optimize the cure rate in the laser treatment of in situ SCC in hair-bearing skin.
Solution
Each lesion was treated with three passes of the CO 2 laser utilizing a 3 mm handpiece at 500 mJ. A surrounding 5 mm margin was included in the laser treatment field. Immediately thereafter a diode laser was used as a final pass at 60 J/cm 2 , a 30-msec pulse duration, and a 9 mm ϫ 9 mm spot size. Four millimeter punch biopsy specimens were obtained before laser treatment, immediately after, 2 weeks, and 2 months postoperatively and sent for routine histologic examination.
Preoperative biopsies revealed full-thickness epidermal atypia and focal areas of follicular extension consistent with Bowen's disease. Skin biopsies obtained immediately following the dual laser regimen demonstrated that CO 2 laser-induced epidermal ablation was evident. In addition, deeper ablation of follicular epithelium was demonstrated, at times extending down to the hair bulb near the subcutaneous tissue. These follicular sites of thermal necrosis could not be accounted for by the CO 2 laser and were likely caused by the diode system. By 2 weeks postoperatively, epidermal and follicular epithelium were restored and maintained at 2 months (Figure 2 ). There was no clinical evidence of Bowen's diseases recurrence at 4 months. All sites healed uneventfully.
Discussion
Traditional modalities to treat in situ SCC, including electrodesiccation and curettage, excision, radiation, and cryotherapy, all have various cure rates and aesthetic outcomes. Although Mohs micrographic surgery attains a high cure rate while minimizing the excision size, large repairs for wide superficial defects may still prove necessary. Continuous wave CO 2 laser tech-nology of the 1980s and early 1990s provided another approach to manage superficial BCCs and in situ processes, such as actinic cheilitis and Bowen's disease. [1] [2] [3] [4] [5] [6] Tissue charring from extreme laser heating, however, results in unacceptable cosmetic outcomes since thermal injury extends beyond the intended target. [7] [8] [9] High-energy, short-pulsed CO 2 laser technologies have been able to achieve vaporization with narrower zones of thermal damage, providing a risk-benefit ratio favorable enough to fuel the aesthetic resurfacing explosion in recent years. [10] [11] [12] Case reports utilizing highenergy, short-pulsed CO 2 lasers to treat in situ SCC and superficial BCC suggest that lesions confined to the epidermis and papillary dermis might be effectively removed in a cosmetically acceptable manner. 13, 14 Humphreys et al. 15 investigated the use of a highenergy, short-pulsed CO 2 laser to ablate superficial BCCs and in situ SCCs. Thirty neoplasms were treated with a pulsed CO 2 laser using 3 mm margins and either two or three passes. Each neoplasm was then immediately excised. Histologic assessment confirmed complete ablation of superficial BCCs with three passes, corresponding to laser damage to the upper reticular dermis. Persistent in situ SCC was seen at the deep margins in three of seven patients treated with three passes. Lesions treated with only two passes showed higher rates of incomplete removal at the deep margins for both BCC and Bowen's disease. One BCC and three in situ SCC specimens in their study maintained positive peripheral margins after laser treatment. It was concluded that while three laser passes may be an effective modality for treating superficial BCCs, in situ SCCs were variably responsive. Residual in situ SCC disease was associated with lesions that were hyperplastic, hyperkeratotic, or demonstrated follicular extension.
In all of our cases the in situ SCC lesions were minimally hyperkeratotic, yet all were situated on hairbearing surfaces. Given the propensity for Bowen's disease to extend into the follicular infundibula, 16 we were concerned about the recurrence rate following CO 2 laser ablation alone.
Laser-assisted hair removal has rapidly gained popularity over the last several years and now includes a variety of technologies from solid crystal systems (ruby, alexandrite, Nd:YAG) to diode and intense pulsed light sources. 17 Laser hair ablation utilizes dark terminal hair as the chromophore to rupture the follicular unit. Heat is generated in the hair shaft which is transmitted to the surrounding follicular epithelium. 18 Biopsies following laser treatment have demonstrated heat-induced follicular damage to the outer root sheath at high fluences (ie. Ͼ 40 J/cm 2 ), at times to the level of the hair bulb. [19] [20] [21] We proposed that the cure rate of laser removal of in situ SCCs in nonglabrous skin might increase by employing both ultrapulsed CO 2 laser and hair ablative systems. Three passes with the ultrapulsed CO 2 laser with 5 mm margins were utilized to ablate the bulk of the lesion and provide a more uniform surface for a high-fluence diode hair removal pass. The diode laser caused damage to the follicular epithelium too deep and target-specific for the CO 2 laser to achieve. Since follicular reepithelialization without atypia was the sufficient endpoint, additional diode laser sessions were not pursued since prolonged hair removal was not necessary or desired. We chose the highest settings available on our diode laser (60 J fluence, 30-msec pulse duration) in order to maximize the chance that laser-induced thermal injury at the follicular level would be detectable in this preliminary study.
We conclude that these cases suggest at least a theoretical basis for introducing concomitant CO 2 laser and hair ablation in the treatment of in situ SCCs in nonglabrous skin in order to enhance the cure rate. Long-term clinical and histologic follow-up is neces- Figure 1 . A) Bowen's disease on the midchest with multiple hairs extending from it and the surrounding skin. B) Four months after CO 2 and diode laser ablation. Erythema is fading, hair growth has resumed, with no evidence of persistent or current disease to date.
sary. The percentage increase in cure rate needs to be quantified. Additional prospective trials comparing the recurrence rate with CO 2 plus diode treatment versus CO 2 treatment alone are warranted. It should be noted, however, that this approach is currently limited to those lesions with dark and relatively coarse terminal hairs, which provide effective chromophore targets for the currently available hair removal lasers.
